SEER
Showing 1 - 25 of 177
Tumor Size and Prognosis in Small Bowel adenocarcinoma-a
Completed
- Prognosis
- no interventions
-
Dalian, Liaoning, ChinaDalian Third People's Hospital Affiliated to Dalian Medical Univ
Oct 11, 2023
Novel Staging Schemes for Siewert Type II Esophagogastric
Completed
- Adenocarcinoma of the Esophagogastric Junction
- esophagogastric junction cancer surgery
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Nov 1, 2022
GastroIntestinal Cancer in Children and Adolescents
Active, not recruiting
- Gastrointestinal Cancer
- +6 more
-
Leiden, South-Holland, Netherlands
- +1 more
Jan 11, 2023
Epilepsy Trial in Melbourne (EpiTel Epilog, Empatica E4, GENEActiv)
Enrolling by invitation
- Epilepsy
- EpiTel Epilog
- +2 more
-
Melbourne, Victoria, AustraliaSeer Medical
Sep 20, 2021
Genetic Aspects of Chordoma: A Collaboration With SEER
Completed
- Chordoma
-
Iowa City, Iowa
- +1 more
Jul 9, 2020
Validation of a Seizure Monitoring System
Completed
- Epilepsy
- Medtronic LINQ Device
-
Melbourne, Victoria, AustraliaSt Vincent's Hospital Melbourne
Oct 25, 2020
Gonadal and Extra-gonadal Malignant Teratomas
Completed
- SEER Database
- survival rates
- (no location specified)
Sep 15, 2020
Compare Overall Survival in Medicare Metastatic Breast Cancer
Active, not recruiting
- Breast Cancer
- Palbociclib
- Aromatase Inhibitor
-
New York, New YorkPfizer New York
Oct 11, 2023
Increased Lymph Node Yield in Colorectal Cancer Synchronous
Completed
- Colorectal Cancer Stage IV
- Lymph Node Yield
- lymph node yield
-
Harbin, Heilongjiang, ChinaEthics and ethics of the Second Affiliated Hospital of Harbin Me
Dec 19, 2022
Quantra QPlus Sample Type Comparison
Completed
- Coagulation Defect; Bleeding
- Quantra QPlus System
-
Columbus, OhioOhio State University Wexner Medical Center
Nov 18, 2022
Bladder Cancer, Urothelial Carcinoma, Hematuria Trial (Urinalysis)
Not yet recruiting
- Bladder Cancer
- +3 more
- Urinalysis
- (no location specified)
Dec 1, 2022
Routine Treatment of Prostate Cancer
Not yet recruiting
- Prostate Cancer
- Radiotherapy
- (no location specified)
Jan 10, 2023
NSCLC Trial in Boston, New York (MPDL3280A, Carboplatin, Nab-paclitaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- MPDL3280A
- +2 more
-
Boston, Massachusetts
- +1 more
Oct 12, 2022
Evaluation of the Quantra QStat System in Obstetric Patients
Not yet recruiting
- Blood Loss Massive
- Post Operative Hemorrhage
- Quantra System
-
Durham, North CarolinaDuke University Hospital
May 19, 2023
Locally Advanced Non Small Cell Lung Cancer Patients in Brazil
Completed
- Lung Cancer, Non-small Cell
-
Salvador, BA, Brazil
- +10 more
Jan 5, 2023
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Recruiting
- Xeroderma Pigmentosum
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
The Canadian/US Integrative Oncology Study
Active, not recruiting
- Breast Neoplasms
- +3 more
-
Scottsdale, Arizona
- +11 more
Oct 21, 2022
Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ
Completed
- Ductal Carcinoma In Situ
- Sentinel lymph node biopsy (SLNB)
-
Bethesda, MarylandSEER-Medicare Dataset
May 1, 2019
Pancreas Cancer, Exosomes, Extracellular Vesicles Trial
Not yet recruiting
- Pancreas Cancer
- +3 more
- (no location specified)
Dec 6, 2022
Surgical Therapy and Survival in HCC/ C.F. Zhang et al.
Completed
- Hepatocellular Carcinoma
- Surgery
-
Guangzhou, Guangdong, Chinalinzhu Zhai
Mar 27, 2021
Advanced Colorectal Neoplasm Risk Categories inProspective
Recruiting
- Colorectal Cancer Screening
- Fecal inmunochemical test
- +2 more
-
Mexico City, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Jan 24, 2023
Children and Adults With Olfactory Neuroblastoma
Recruiting
- Olfactory Neuroblastoma
- Esthesioneuroblastoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Human Epilepsy Project 3
Recruiting
- Idiopathic Generalized Epilepsy
-
San Francisco, California
- +17 more
May 11, 2022